Sources: Bayer offers animal health biz, cash for Merck’s OTC unit

Eric Palmer

When bidding wars get hot, that often springs information leaks. The latest is that there is some swap-and-shop haggling going on between and Merck over Merck's consumer business. That, at least, is what are telling Reuters.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS